Heterocyclic inhibitors of mek and methods of use thereof

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/42 (2006.01) C07D 261/20 (2006.01)

Patent

CA 2537321

Disclosed are compounds of the Formula (I) and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9 and R10, W and Y are defined in the specification. Such compounds are MEK inhibitors and useful in the treament of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed are methods of using such compounds in the treatment of hyperproliferative disease in mammals and pharmaceutical compositons conataining such compounds.

L'invention porte sur des composés de la formule (I) et sur des sels et des promédicaments de ce dernier pharmaceutiquement acceptables, R?1¿, R?2¿, R?7¿, R?8¿, R?9¿ et R?10¿, W et Y étant définis dans le descriptif. Ces composés sont des inhibiteurs de MEK et sont utiles dans le traitement des maladies hyperprolifératives, telles que le cancer et l'inflammation, chez les mammifères. L'invention se rapporte aussi à des procédés d'utilisation de ces composés dans le traitement des maladies hyperprolifératives chez les mammifères et à des compositions pharmaceutiques contenant ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic inhibitors of mek and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic inhibitors of mek and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic inhibitors of mek and methods of use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1353394

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.